Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Covington
Harvard Business School
Baxter
Boehringer Ingelheim
Cerilliant
Citi
Federal Trade Commission
Moodys

Generated: May 20, 2018

DrugPatentWatch Database Preview

Prednisolone sodium phosphate - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for prednisolone sodium phosphate and what is the scope of prednisolone sodium phosphate freedom to operate?

Prednisolone sodium phosphate
is the generic ingredient in thirteen branded drugs marketed by Merck, Watson Labs, Novartis, Schering, Pharmafair, Akorn, Alcon Pharms Ltd, Bausch And Lomb, Sola Barnes Hind, Concordia Pharms Inc, Seton Pharm, Amneal Pharms, Chartwell Rx, Edenbridge Pharms, Hi Tech Pharma, Medicis Pharms, Mission Pharma, Nesher Pharms, Pharm Assoc, Vintage, Vintage Pharms, We Pharms, Wockhardt Bio Ag, Mylan Pharms Inc, and Sandoz Inc, and is included in forty-one NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Prednisolone sodium phosphate has nine patent family members in seven countries.

There are eighty-six drug master file entries for prednisolone sodium phosphate. Twenty-three suppliers are listed for this compound.
Pharmacology for prednisolone sodium phosphate
Synonyms for prednisolone sodium phosphate
(2-{14,17-DIHYDROXY-2,15-DIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL}-2-OXOETHOXY)PHOSPHONIC ACID
[2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] dihydrogen phosphate
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] dihydrogen phosphate
11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate)
11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-(disodium phosphate)
11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione21-
125-02-0
125P020
302-25-0
752SY38R6C
A805337
AB01563113_01
AC-2371
AC1L1J72
AC1L1LDT
AC1L2HDG
AC1L9B41
ACN-043360
AKOS015962823
AKOS025294226
AKOS025310687
AKOS025394281
AN-14017
ANW-41116
API0003920
AT-2935
BC214767
C21H27O8P.2Na
CCG-213527
CHEBI:8379
CHEMBL1201014
CHEMBL1201231
Codelsol
Cortisate-20 (Veterinary)
CS-2878
CTK8B2822
CTK8I0968
D00981
D3918
disodium [2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl] phosphate
disodium [2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] phosphate
disodium [2-[(8S,9S,10R,11S,13S,14S,17R)-10,13-dimethyl-11,17-bis(oxidanyl)-3-oxidanylidene-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxidanylidene-ethyl] phosphate
disodium [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate
DISODIUM 14,17-DIHYDROXY-2,15-DIMETHYL-14-[2-(PHOSPHONATOOXY)ACETYL]TETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-5-ONE
Disodium prednisolone 21-phosphate
disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate
DTXSID2047480
DTXSID7047481
EINECS 204-722-9
EINECS 206-120-1
FT-0631728
HMS3264J09
HY-B0645
I06-0770
Inflamase
Inflamase Forte
Inflamase Mild
IV021NXA9J
KB-296232
LS-118502
LS-174283
LS-187308
Metreton
MFCD00083682
MolPort-019-991-120
NCGC00249889-01
NSC-759187
NSC759187
Optimyd
Optival
Pediapred (TN)
Pharmakon1600-01505712
Phortisolone
PL008904
PL043604
Predair
Predair Forte
Prednesol
Prednisolone (disodium phosphate)
Prednisolone 21-(dihydrogen phosphate)
Prednisolone 21-(disodium phosphate)
Prednisolone 21-phosphate disodium
Prednisolone 21-Phosphate Disodium Salt
Prednisolone disodium phosphate
Prednisolone phosphate
Prednisolone phosphate sodium
Prednisolone Phosphoric Acid
Prednisolone sodium phosphate (JP17/USP)
Prednisolone Sodium Phosphate [USAN:JAN]
Prednisolone sodium phosphate [USP:JAN]
Predsol
Predsolan
Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-, 21-(dihydrogen phosphate), disodium salt
Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-, 21-(dihydrogen phosphate),disodium salt
Pregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-(phosphonooxy)-, disodium salt, (11.beta.)-
Pregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-(phosphonooxy)-, disodium salt, (11beta)-
Prozorin
PSLP
Q-201615
SBI-0206886.P001
SCHEMBL136773
SCHEMBL1650407
SCHEMBL23563
sodium 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl phosphate
Sodium prednisolone phosphate
Solucort
ST24049032
TR-003806
UNII-752SY38R6C
UNII-IV021NXA9J
VA11575
Vasocidin Solution
ZINC4097473

US Patents and Regulatory Information for prednisolone sodium phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmafair PREDAIR prednisolone sodium phosphate SOLUTION/DROPS;OPHTHALMIC 088415-001 Feb 29, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharm Assoc PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate SOLUTION;ORAL 078988-001 Jun 9, 2008 AA RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 202179-003 Apr 10, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vintage Pharms PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate SOLUTION;ORAL 078416-001 Oct 31, 2007 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for prednisolone sodium phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Concordia Pharms Inc ORAPRED ODT prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 021959-003 Jun 1, 2006 ➤ Sign Up ➤ Sign Up
Concordia Pharms Inc ORAPRED ODT prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 021959-001 Jun 1, 2006 ➤ Sign Up ➤ Sign Up
Concordia Pharms Inc ORAPRED ODT prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 021959-003 Jun 1, 2006 ➤ Sign Up ➤ Sign Up
Seton Pharm PEDIAPRED prednisolone sodium phosphate SOLUTION;ORAL 019157-001 May 28, 1986 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
US Army
Johnson and Johnson
Farmers Insurance
Covington
Medtronic
Moodys
Fish and Richardson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.